期刊文献+

血清β-胶原降解产物及骨钙素联合检测评价骨转换的意义 被引量:18

Evaluation of bone turnover by detecting serum beta-collagen degradation products and osteocalcin concentration
下载PDF
导出
摘要 目的:分析中老年人骨密度与血清β-胶原降解产物、骨钙素的关系,以及其在骨质疏松症中评价骨转换的价值。方法:①选择来自厦门大学附属中山医院老年科2003-06/2005-06门诊健康体检者238例,年龄50~86岁。正常组99例,女69例,男30例,骨质疏松症组139例,女94例,男45例,两组均以每10岁为1个年龄组。②采集受试者空腹时肘静脉血,采用电化学发光免疫分析法分析血清β-胶原降解产物、骨钙素的含量,同时用LUNAR双能X射线骨密度仪测量髋骨骨密度。观察两组股骨头、大转子、Ward三角区骨密度,β-胶原降解产物和骨钙素浓度变化。结果:纳入238例,全部进入结果分析。①健康人血清中的β-胶原降解产物与年龄呈正相关(r=0.7629,P<0.05),骨钙素水平与年龄呈负相关(r=-0.9897,P<0.05),二者都与性别无关(P>0.05)。②骨质疏松症各年龄组的β-胶原降解产物水平高于正常组(P<0.01),骨钙素水平低于正常组(P<0.05)。③50岁以上骨质疏松症患者股骨颈、大转子、Ward三角区骨密度较正常组显著下降(P<0.01)。④骨质疏松症患者各部位骨密度与β-胶原降解产物和骨钙素浓度无相关性。⑤β-胶原降解产物骨钙素分别取截断值时,诊断敏感性为69.6%,21.5%,特异性为70.0%,78.3%,阳性似然比为2.32,0.99,阴性似然比为0.434,1.002,假阳性率为30.0%,21.6%,假阴性率为30.3%,78.4%,阳性预测值为75.3%,56.6%,阴性预测值为63.6%,43.1%。联合检测两指标,诊断的敏感性达77.2%。结论:联合检测血清β-胶原降解产物、骨钙素、骨密度能全面合理评价骨转换,在中老年骨质疏松症的早期筛查及诊断,预防危险性骨损伤发生中具有重要的临床指导价值。 AIM: To investigate the relationship among bone mineral density, serum type Ⅰ collagen degradation products (β-Crosslaps) and osteocalcin (BGP), so as to explore the clinical value in evaluating bone turnover in patients with osteoporosis. METHODS: ①Totally 238 healthy physical examinees aged 50-86 years from Department of Gerontology of Zhongshan Hospital, Xiamen Unviersity between June 2003 and June 2005 were selected. The subjects were divided into normal group (n =99) included 69 females and 30 males, and osteoporosis group (n =139) included 94 females and 45 males. The two groups were subdivided into age groups by 10 years old. ②The blood from ulnar vein was collected from the subjects in fasting to detect the concentrations of β-Crosslaps and BGP by ECLIA. The haunch bone mineral density was measured by dual energy X-ray absorptimetry to observe the changes in the bone mineral density of caput femods, trochanter and Ward trigone, and the concentrations of β-Crosslaps and BGP RESULTS: All 238 subjects were involved in the result analysis. ①Serum level of β-Crosslaps was correlated positively with age in normal people (r =0.762 9, P 〈 0.05), while serum BGP was correlated negatively with age (r =-0.989 7, P 〈 0.05). Both of them had no correlation with sex (P 〉 0.05). ②Patients with osteoporosis in different age groups had an incresse trend of β-Crosslaps (P 〈 0.01) and decrease of BGP (P 〈 0.05) compared with the normal group. ③in the patients with osteoporosis over 50 years, the bone mineral density in neck, trochiter and Ward tdangle was significantly lower than that of the normal group (P 〈 0.01). ④β-Crosslaps and BGP were not correlated to bone mineral density in various parts of body of the patients. ⑤in terms of the cutoff value of β-Cresslaps and BGP, the diagnosis sensitivity were 69.6%, 21.5%, specificity 70.0%,78.3%, positive likelihood ratio 2.32, 0.99, negative likelihood ratio 0.434,1.002, false positive rate 30
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2007年第2期268-270,共3页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献19

  • 1Lavelle WF,Cheney R.Recurrent fracture after vertebral kyphoplasty.Spine J 2006;6(5):488-493 被引量:1
  • 2何伟东,柯楚群,许鸿灏,黄新宇,林毅忠,李松军.老年桡骨远端骨折患者骨组织形态计量分析[J].第四军医大学学报,2005,26(13):1200-1202. 被引量:5
  • 3李平生,韦兴,殷亚昕,唐志雄,彭朝津,张瑾,刘加昌,候晓霞,蔺静,黄志红,欧阳巧洪.骨质疏松症骨代谢生化指标与骨密度测量分析[J].中国骨质疏松杂志,2005,11(1):22-24. 被引量:23
  • 4Srivastava AK,MacFarlane G,Srivastava VP,et al.A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type Ⅰ collagen in urine.Calcif Tissue Int 2001;69(6):327-336 被引量:1
  • 5Filip RS,Zagórski J.Age and BMD related differences in biochemical markers of bone metabolism in rural and urban women from Lublin Region,Poland.Ann Agric Environ Med 2004; 11(2):255-259 被引量:1
  • 6Lanthier J,Desrosiers RR.Protein L-isoaspartyl ethyltransferase repairs abnormal aspartyl residues accumulated in vivo in type-Ⅰ collagen and restores cell migration.Exp Cell Res 2004;293(1):96-105 被引量:1
  • 7Bonde M,Garnero P,Fledelius C,et al.Measurement of bone degradation products in serum using antibodies reactive with anisomeride form of an aminoacid sequence of the C-telopeptide of type Icollagen.J Bone Miner Res 1997;12(7):1028-1034 被引量:1
  • 8Okabe R,Inaba M,Nakatsuka K,et al:Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type Ⅰ collagen and urinary deoxypyridinoline.J Bone Miner Metab 2004;22(2):127-131 被引量:1
  • 9Zoli A,Lizzio MM,Capuano A,et al.Osteoporosis and bone metabolism in postmenopausal women with osteoarthritis of the hand.Menopause 2006;13(3):462-466 被引量:1
  • 10Huber F,Traber L,Roth HJ,et al.Markers of bone resorption-measurement in serum,plasma or urine.Clin Lab 2003;49(5-6):203-207 被引量:1

二级参考文献83

  • 1徐伟,杨蕊敏,王吉耀,朱继珩,诸骏仁.骨代谢生化指标诊断骨质疏松症的价值[J].中国骨质疏松杂志,1999,5(1):16-18. 被引量:9
  • 2余卫,秦明伟,徐苓,田均平,邢小平,孟迅吾,曹坚,严洪珍,葛秦生.正常人腰椎骨密度变化(附445例双能X线骨密度仪测量分析)[J].中华放射学杂志,1996,30(9):625-629. 被引量:57
  • 3[1]BOND M.Immunoassay for quantifying type Ⅰ collagen degradation products in urine evaluated[J].Clin Chem,1994,40:2022-2025. 被引量:1
  • 4[2]GARNERO P,GINEYTS E,DEIMAS PD.Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease[J].J Clin Endoccrinol Metab,1994,79:780-785. 被引量:1
  • 5[3]GARNERO P,GRIMAUX M,SEGUIN P,et al.Characterization of immunoreactive forms of human ostercalcin generated in vivo and in vitro[J].J Bone Miner Res,1994,9(2):255-264. 被引量:1
  • 6[4]NILAS L,CHRISTIANSEN C.Bone mass and its relationship to age and the menopause[J].J Clin Endocrinol Metab,1987,65(4):697-702. 被引量:1
  • 7[5]G RONALD,C KATHERINE.Prevention of diabetic vascular dysfunction of nitric oxide synthase versus advanced glucotion end-product formation[J].Diabetes,1993,42:220-226. 被引量:1
  • 8Toquet J,Rohanizadeh R. Osteogenic potential in vitro of human bone marrow cells cultured on macroporous biphasic calcium phosphate ceramic [J ]. J Biomed Mater Res, 1999;144 (1): 98-108. 被引量:1
  • 9Kahn A, Gibbons R, Perkins S, et al. Aged-related bone loss: A hypothesis and initial assessment in mice [J]. Clin Orthop, 1995;313:69-75. 被引量:1
  • 10Owen M. Marrow stromal stem cells [J]. J Cell Sci, 1988; 10(suppl): 61-76. 被引量:1

共引文献63

同被引文献185

引证文献18

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部